Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.77 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.77 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.53 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.53 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.53 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.599NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.599NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.599NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.128NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.128NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.128NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.451NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.451NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.451NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.313NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.313NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.313NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.402NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.402NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.402NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.609NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.609NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.609NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.344NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.344NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.344NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.556NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.556NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.556NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.245NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.245NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.245NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.403NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.403NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.403NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.636NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.636NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.636NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.126NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.126NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.126NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.47NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.47NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used